PATENT CLAIM ANALYSIS

Application Number: 16053596
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2020-02
Patent Classification: ["null", "null"]

Abstract:
The invention introduces a method of inhibiting abuse potential and psychosis associated with long term use of apomorphine. Apomorphine used for the treatment of motor symptoms in Parkinson's disease produces addiction, and psychosis. The present method shows that apomorphine plus buspirone combination in the ratio of 1:1 will not produce psychosis. The combination will not be addictive too.

Claim (Index 3):
The method of  claim 1 , wherein the memory loss is associated with Parkinsonism.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 96.0
- Lexical Diversity: 1.3913
- Patent Class: nan
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15231239', '13879128', '14937286', '12101943', '14395134']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5158218928455032
- 35 USC 102 Novelty (BERT): 0.5038817814627025
- Combined Prediction Score: 0.5146278817072231
- Mean Citation Score: 213.68994000000004
- Max Citation Score: 219.08601
- Similarity Product: 133.7721275154537

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test